Correlation Between Painreform and Regencell Bioscience

Can any of the company-specific risk be diversified away by investing in both Painreform and Regencell Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Painreform and Regencell Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Painreform and Regencell Bioscience Holdings, you can compare the effects of market volatilities on Painreform and Regencell Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Painreform with a short position of Regencell Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Painreform and Regencell Bioscience.

Diversification Opportunities for Painreform and Regencell Bioscience

-0.37

Correlation Coefficient

Painreform  Regencell Bioscience

Very good diversification

The 3 months correlation between Painreform and Regencell is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Painreform and Regencell Bioscience Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regencell Bioscience and Painreform is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Painreform are associated (or correlated) with Regencell Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regencell Bioscience has no effect on the direction of Painreform i.e., Painreform and Regencell Bioscience go up and down completely randomly.

Pair Corralation between Painreform and Regencell Bioscience

Given the investment horizon of 90 days Painreform is expected to generate 20.75 times more return on investment than Regencell Bioscience. However, Painreform is 20.75 times more volatile than Regencell Bioscience Holdings. It trades about 0.15 of its potential returns per unit of risk. Regencell Bioscience Holdings is currently generating about -0.22 per unit of risk. If you would invest  337.00  in Painreform on October 10, 2024 and sell it today you would earn a total of  8.00  from holding Painreform or generate 2.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

Painreform  vs.  Regencell Bioscience Holdings

Painreform

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Painreform are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Painreform showed solid returns over the last few months and may actually be approaching a breakup point.

Regencell Bioscience

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Regencell Bioscience Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Painreform and Regencell Bioscience

The main advantage of trading using opposite Painreform and Regencell Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Painreform position performs unexpectedly, Regencell Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regencell Bioscience will offset losses from the drop in Regencell Bioscience's long position.

The idea behind Painreform and Regencell Bioscience Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.